Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anticoagulation for VTE: Impact on the Risk of Major Adverse Cardiovascular Events.
Noumegni SR, Le Mao R, de Moreuil C, Hoffmann C, Le Moigne E, Tromeur C, Mansourati V, Nasr B, Gentric JC, Guegan M, Poulhazan E, Bressollette L, Lacut K, Didier R, Couturaud F. Noumegni SR, et al. Among authors: gentric jc. Chest. 2022 Nov;162(5):1147-1162. doi: 10.1016/j.chest.2022.05.038. Epub 2022 Jun 15. Chest. 2022. PMID: 35714709
Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
Noumegni SR, Didier R, Mansourati V, Tromeur C, Le Moigne E, Hoffmann C, Nasr B, Gentric JC, Guegan M, Poulhazan E, Lacut K, Bressollette L, Le Mao R, Couturaud F. Noumegni SR, et al. Among authors: gentric jc. Thromb Res. 2022 Jun;214:93-105. doi: 10.1016/j.thromres.2022.04.016. Epub 2022 Apr 29. Thromb Res. 2022. PMID: 35525202
Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study.
Noumegni SR, Didier R, Mansourati V, Moigne EL, Mao RL, Hoffmann C, Moreuil C, Tromeur C, Roux PL, Nasr B, Gentric JC, Guegan M, Poulhazan E, Lacut K, Bressollette L, Couturaud F. Noumegni SR, et al. Among authors: gentric jc. Semin Thromb Hemost. 2022 Jun;48(4):465-480. doi: 10.1055/s-0042-1748152. Epub 2022 Jun 30. Semin Thromb Hemost. 2022. PMID: 35772402
Predictors of Recurrent Venous Thromboembolism or Arterial Thrombotic Events during and after Anticoagulation for a First Venous Thromboembolism.
Noumegni SR, Tromeur C, Hoffmann C, Mao RL, Moigne EL, Moreuil C, Mansourati V, Nasr B, Gentric JC, Guegan M, Poulhazan E, Bressollette L, Lacut K, Didier R, Couturaud F. Noumegni SR, et al. Among authors: gentric jc. Semin Thromb Hemost. 2023 Oct;49(7):688-701. doi: 10.1055/s-0042-1757899. Epub 2022 Oct 17. Semin Thromb Hemost. 2023. PMID: 36252603
Late Outcomes of Carotid Artery Stenting for Radiation Therapy-Induced Carotid Stenosis.
Nasr B, Crespy V, Penasse E, Gaudry M, Rosset E, Feugier P, Gouëffic Y, Maurel B, Hostalrich A, Alric P, Sadaghianloo N, Settembre N, Chevallier J, Ben Ahmed S, Gouny P, Steinmetz E; Association Universitaire Pour la Recherche en Chirurgie (AURC) Group. Nasr B, et al. J Endovasc Ther. 2022 Dec;29(6):921-928. doi: 10.1177/15266028211068757. Epub 2022 Jan 10. J Endovasc Ther. 2022. PMID: 35012391
Endovascular treatment of brain arteriovenous malformations: clinical outcomes of patients included in the registry of a pragmatic randomized trial.
Raymond J, Gentric JC, Magro E, Nico L, Bacchus E, Klink R, Cognard C, Januel AC, Sabatier JF, Iancu D, Weill A, Roy D, Bojanowski MW, Chaalala C, Barreau X, Jecko V, Papagiannaki C, Derrey S, Shotar E, Cornu P, Eker OF, Pelissou-Guyotat I, Piotin M, Aldea S, Beaujeux R, Proust F, Anxionnat R, Costalat V, Corre ML, Gauvrit JY, Morandi X, Brunel H, Roche PH, Graillon T, Chabert E, Herbreteau D, Desal H, Trystram D, Barbier C, Gaberel T, Nguyen TN, Viard G, Gevry G, Darsaut TE; TOBAS Collaborative Group; Collaborators in the TOBAS Collaborative Group. Raymond J, et al. Among authors: gentric jc. J Neurosurg. 2022 Oct 28;138(5):1393-1402. doi: 10.3171/2022.9.JNS22987. Print 2023 May 1. J Neurosurg. 2022. PMID: 37132535 Clinical Trial.
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial.
Fischer U, Kaesmacher J, Strbian D, Eker O, Cognard C, Plattner PS, Bütikofer L, Mordasini P, Deppeler S, Pereira VM, Albucher JF, Darcourt J, Bourcier R, Benoit G, Papagiannaki C, Ozkul-Wermester O, Sibolt G, Tiainen M, Gory B, Richard S, Liman J, Ernst MS, Boulanger M, Barbier C, Mechtouff L, Zhang L, Marnat G, Sibon I, Nikoubashman O, Reich A, Consoli A, Lapergue B, Ribo M, Tomasello A, Saleme S, Macian F, Moulin S, Pagano P, Saliou G, Carrera E, Janot K, Hernández-Pérez M, Pop R, Schiava LD, Luft AR, Piotin M, Gentric JC, Pikula A, Pfeilschifter W, Arnold M, Siddiqui AH, Froehler MT, Furlan AJ, Chapot R, Wiesmann M, Machi P, Diener HC, Kulcsar Z, Bonati LH, Bassetti CL, Mazighi M, Liebeskind DS, Saver JL, Gralla J; SWIFT DIRECT Collaborators. Fischer U, et al. Among authors: gentric jc. Lancet. 2022 Jul 9;400(10346):104-115. doi: 10.1016/S0140-6736(22)00537-2. Lancet. 2022. PMID: 35810756 Clinical Trial.
125 results